| Title |
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2019
|
| DOI | 10.1002/14651858.cd013487 |
| Pubmed ID | |
| Authors |
Vanessa Piechotta, Tina Jakob, Peter Langer, Ina Monsef, Christof Scheid, Lise J Estcourt, Sunday Ocheni, Sebastian Theurich, Kathrin Kuhr, Benjamin Scheckel, Anne Adams, Nicole Skoetz |
Twitter Demographics
The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | 10% |
| Qatar | 1 | 5% |
| Portugal | 1 | 5% |
| Ireland | 1 | 5% |
| United Kingdom | 1 | 5% |
| United States | 1 | 5% |
| Unknown | 13 | 65% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 80% |
| Practitioners (doctors, other healthcare professionals) | 3 | 15% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 161 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 20 | 12% |
| Other | 19 | 12% |
| Researcher | 18 | 11% |
| Student > Master | 14 | 9% |
| Student > Ph. D. Student | 12 | 7% |
| Other | 20 | 12% |
| Unknown | 58 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 22% |
| Nursing and Health Professions | 12 | 7% |
| Biochemistry, Genetics and Molecular Biology | 10 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Psychology | 7 | 4% |
| Other | 23 | 14% |
| Unknown | 64 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2023.
All research outputs
#1,067,873
of 24,486,486 outputs
Outputs from Cochrane database of systematic reviews
#2,261
of 12,927 outputs
Outputs of similar age
#26,061
of 468,191 outputs
Outputs of similar age from Cochrane database of systematic reviews
#31
of 186 outputs
Altmetric has tracked 24,486,486 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,927 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 468,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 186 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.